Infectious Disease Diagnostics Market by Product Type (Kits & Reagents, and Instruments), By Disease Type (HIV, Hepatitis, Healthcare Associated Infections (HAIs), Human Papillomavirus (HPV), Tuberculosis (TB), Influenza, and Others), By Technology (Immunodiagnostics, Polymerase Chain Reaction, Next Generation Sequencing, and Others), By Test Location (Laboratory Testing, Point of Care Testing), By End User (Hospitals, Pathology/Diagnostic Laboratories, Research Institutes, Home-Care Settings, and Others), and Region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) - Global Forecast to 2026

  • Published On : Jul 2018 |
  • Pages : 171 Pages |
  • Format : CMI Insight PPT Format CMI Insight PDF Format

Infectious Disease Diagnostics Market – Insights

Infectious diseases are caused by organisms such as bacteria, viruses, fungi, and parasites and are capable of transmission from one species to another species. Diagnosis of these diseases involves identifying the pathogen and its type and the degree up to which the infection has spread. Infectious diseases such as HIV, tuberculosis, malaria, and Influenza are highly prevalent and can be efficiently diagnosed with the help of diagnostic tests available for the respective diseases.

Technologies utilized by these diagnostic tests are classified into biochemical techniques, molecular techniques, immunodiagnostics, and conventional culturing, and staining techniques. Biochemical techniques include ELISA, agglutination, and others, while molecular techniques include Polymerase Chain Reaction (PCR) and Next-Generation Sequencing techniques. These tests are capable of diagnosing the infectious diseases accurately with high throughput capacity.

Advances in molecular testing techniques have resulted in fast diagnosis of infectious diseases in real-time due to which patients can receive treatment early. Commercially available diagnostic tests include BD Max Smart Cycler, GeneXpert, BD Phoenix CPO detect test, Xpert Xpress Strep A, and BioPlex 2200 Syphilis Total & RPR Assay.

Increasing prevalence of various infectious diseases is expected to boost the infectious disease diagnostics market growth over the forecast period

Infectious diseases such as HIV, tuberculosis, and malaria are prevalent in emerging economies such as Africa and Asia Pacific. For instance, according to the World Health Organization (WHO), an estimated 36.7 million people were suffering from HIV in 2016.

According to the World Health Organization (WHO), in 2015, an estimated 32,000 deaths from tuberculosis and around 323,000 new cases of TB cases were registered in the Europe. Moreover, around 323,000 incident of TB cases in this region includes 27,000 cases with HIV co-infection.

According to the data published in the Journal of Infection and Public Health, infectious diseases reported the significant causes of deaths in Brazil, in 2016. The high concentration of burden rates observed among men, children under 5 years of age at the coast regions of the state.

According to the Centers for Disease Control and Prevention (CDC), around 5,251 deaths were reported due to influenza infection were registered in 2015. According to the National Ambulatory Medical Care Survey: 2015 data findings, around 16.8 million people visit to physician for treatment of infectious and parasitic diseases in U.S.

According to the World Health Organization (WHO), 2016, around 10.4 million people were affected with tuberculosis and an estimated 1 million pediatric population was affected with tuberculosis. Increasing prevalence of diseases would propel the infectious disease diagnostics market.

The global infectious disease diagnostics market size was valued at US$ 15,112.2 million in 2017, and is expected to witness a robust CAGR of 6.1% over the forecast period (2018 – 2026).

Figure 1. Global Infectious Disease Diagnostics Market Size US$ Mn, by Region, 2018

   Source: Coherent Market Insights Analysis (2018)

Partnerships and collaborations by market players to develop novel diagnostic techniques is expected to boost growth of the infectious disease diagnostics market

Individual organizations, manufacturers, and research institutes are forming partnerships, and collaborations to advance research and development of diagnostic tests for infectious diseases. Moreover, funding by individual organizations to advance research is expected to boost the growth of the market over the forecast period. For instance, the University of Virginia’s Global Infectious Diseases Institute funded seven projects designed to tackle challenging problems in infectious diseases worldwide in July 2018. They have formed collaborative teams across diverse academic disciplines to control and treat Zika virus infections and to reduce tuberculosis rates among HIV-infected patients in Africa.  

The New York Governor’s Office announced a research collaboration with Regeneron Pharmaceuticals, Inc. to advance the diagnosis and treatment of tick-borne diseases in June 2018. Moreover, Infectious Diseases Society of America (IDSA) and American Society for Microbiology (ASM) released a guide in July 2018, which is expected to help healthcare providers to understand latest technology trends, and knowledge on when to order which test. These factors are expected to affect the growth of infectious disease diagnostic market over the forecast period.  

Figure 2. Global Infectious Disease Diagnostics Market Share (%), by Test Location, 2018 and 2026

   Source: Coherent Market Insights Analysis (2018)

However, underdeveloped centralized laboratory facilities in emerging economies such as Middle East and Africa are expected to hinder growth of the market over the forecast period. Lack of awareness in healthcare professionals as well as patients towards innovative diagnostic solutions is expected to restrain the infectious disease diagnostics market growth over the forecast period.    

Some of the major players operating in the global infectious disease diagnostics market include Danaher Corporation, Abbott Laboratories, Becton, Dickinson, and Company, F.Hoffmann La-Roche Ltd., Trinity Biotech Plc., Cardinal Health, Inc., BioMérieux, Bio-Rad Laboratories, Inc., AccuBioTech, Co. Ltd., and Acon Laboratories, Inc.

Management of infectious diseases can be done with speedy diagnosis, implementation of preventive, and treatment strategies, and strict adherence to the treatment plan. Infectious diseases are lethal and may lead to death if not managed properly and in time. However, rapid and early diagnosis is the key in efficient management of the infectious diseases. Late diagnosis of the diseases often makes it difficult for proper management of the disease and to keep it from spreading.

As the prevalence of infectious diseases is increasing, the need of effective diagnostic tests is also increasing. Centralized laboratory testing has been the gold standard for disease diagnosis. However, emerging economies such as Africa (West Africa), India, Brazil, and China have limited centralized laboratory facilities. In emerging economies point of care diagnostic would be useful due to unavailability of labs, infrastructure, and trained personnel.   

Market Dynamics

Technological advancements to facilitate speedy diagnosis and extensive product portfolios of infectious disease diagnostics offered by manufacturer’s supports the growth of infectious disease diagnostics market. Manufacturers are indulged in providing novel diagnostic solutions for identifying infectious diseases.

For instance, Becton Dickinson and Company launched first automated phenotypic test, BD Phoenix CPO detect test, to detect and classify carbapenemase-producing organisms (CPO) in 2017. Development of innovative point-of-care diagnostics for infectious diseases, wide applications in remote locations, constant disease outbreaks, and government funding for product development and research is expected to fuel growth of the market.

Key features of the study:

  • This report provides in-depth analysis of infectious disease diagnostics market and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2018 – 2026), considering 2016 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
  • It profiles leading players in the global infectious disease diagnostics market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key companies covered as a part of this study include Danaher Corporation, Abbott Laboratories, Becton, Dickinson, and Company, F. Hoffmann La-Roche Ltd., Trinity Biotech Plc, Cardinal Health, Inc., BioMérieux, Bio-Rad Laboratories, Inc., AccuBioTech Co., Ltd., and Acon Laboratories, Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global infectious disease diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the infectious disease diagnostics market

Detailed Segmentation:

  • Global Infectious Disease Diagnostics Market, By Product Type:
    • Kits & Reagents
    • Instruments
  • Global Infectious Disease Diagnostics Market, By Disease Type:
    • HIV
    • Hepatitis
    • Healthcare Associated Infections (HAIs)
    • Human Papillomavirus (HPV)
    • Tuberculosis (TB)
    • Influenza               
    • Others
  • Global Infectious Disease Diagnostics Market, By Technology:
    • Immunodiagnostics
    • Polymerase Chain Reaction (PCR)
    • Next Generation Sequencing (NGS)
    • Others
  • Global Infectious Disease Diagnostics Market, By Test Location:
    • Laboratory Testing
    • Point-of-Care Testing
  • Global Infectious Disease Diagnostics Market, By End User:
    • Hospitals
    • Pathology/Diagnostic Laboratories
    • Research Institutes
    • Home-Care Settings                   
    • Others
  • Global Infectious Disease Diagnostics Market, By Geography:
    • North America
      • By Product:
        • Kits & Reagents
        • Instruments
      • By Disease Type:
        • HIV
        • Hepatitis
        • Healthcare Associated Infections (HAIs)
        • Human Papillomavirus (HPV)
        • Tuberculosis (TB)
        • Influenza               
        • Others
      • By Technology:
        • Immunodiagnostics
        • Polymerase Chain Reaction (PCR)
        • Next Generation Sequencing (NGS)
        • Others
      • By Test Location
        • Laboratory Testing
        • Point-of-Care Testing
      • By End User:
        • Hospitals
        • Pathology/Diagnostic Laboratories
        • Research Institutes
        • Home-Care Settings                  
        • Others
      • By Country:
        • U.S.
        • Canada
    • Europe
      • By Product:
        • Kits & Reagents
        • Instruments 
      • By Disease Type:
        • HIV
        • Hepatitis
        • Healthcare Associated Infections (HAIs)
        • Human Papillomavirus (HPV)
        • Tuberculosis (TB)
        • Influenza               
        • Others
      • By Technology:
        • Immunodiagnostics
        • Polymerase Chain Reaction (PCR)
        • Next Generation Sequencing (NGS)
        • Others
      • By Test Location
        • Laboratory Testing
        • Point-of-Care Testing
      • By End User:
        • Hospitals
        • Pathology/Diagnostic Laboratories
        • Research Institutes
        • Home-Care Settings                  
        • Others
      • By Country:
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Product:
        • Kits & Reagents
        • Instruments
      • By Disease Type:
        • HIV
        • Hepatitis
        • Healthcare Associated Infections (HAIs)
        • Human Papillomavirus (HPV)
        • Tuberculosis (TB)
        • Influenza               
        • Others
      • By Technology:
        • Immunodiagnostics
        • Polymerase Chain Reaction (PCR)
        • Next Generation Sequencing (NGS)
        • Others
      • By Test Location
        • Laboratory Testing
        • Point-of-Care Testing
      • By End User:
        • Hospitals
        • Pathology/Diagnostic Laboratories
        • Research Institutes
        • Home-Care Settings                  
        • Others
      • By Country:
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • By Product:
        • Kits & Reagents
        • Instruments
      • By Disease Type:
        • HIV
        • Hepatitis
        • Healthcare Associated Infections (HAIs)
        • Human Papillomavirus (HPV)
        • Tuberculosis (TB)
        • Influenza               
        • Others
      • By Technology:
        • Immunodiagnostics
        • Polymerase Chain Reaction (PCR)
        • Next Generation Sequencing (NGS)
        • Others
      • By Test Location
        • Laboratory Testing
        • Point-of-Care Testing
      • By End User:
        • Hospitals
        • Pathology/Diagnostic Laboratories
        • Research Institutes
        • Home-Care Settings                  
        • Others
      • By Country:
        • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East
      • By Product:
        • Kits & Reagents
        • Instruments
      • By Disease Type:
        • HIV
        • Hepatitis
        • Healthcare Associated Infections (HAIs)
        • Human Papillomavirus (HPV)
        • Tuberculosis (TB)
        • Influenza               
        • Others
      • By Technology:
        • Immunodiagnostics
        • Polymerase Chain Reaction (PCR)
        • Next Generation Sequencing (NGS)
        • Others
      • By Test Location
        • Laboratory Testing
        • Point-of-Care Testing
      • By End User:
        • Hospitals
        • Pathology/Diagnostic Laboratories
        • Research Institutes
        • Home-Care Settings                  
        • Others
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Product:
        • Kits & Reagents
        • Instruments
      • By Disease Type:
        • HIV
        • Hepatitis
        • Healthcare Associated Infections (HAIs)
        • Human Papillomavirus (HPV)
        • Tuberculosis (TB)
        • Influenza               
        • Others
      • By Technology:
        • Immunodiagnostics
        • Polymerase Chain Reaction (PCR)
        • Next Generation Sequencing (NGS)
        • Others
      • By Test Location
        • Laboratory Testing
        • Point-of-Care Testing
      • By End User:
        • Hospitals
        • Pathology/Diagnostic Laboratories
        • Research Institutes
        • Home-Care Settings                  
        • Others
      • By Country:
        • Central Africa
        • South Africa
        • North Africa
  • Company Profiles
    • Danaher Corporation*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Strategies
      • Recent Developments
    • Abbott Laboratories
    • Becton, Dickinson, and Company
    • Hoffmann La-Roche Ltd.
    • Trinity Biotech Plc
    • Cardinal Health, Inc.
    • BioMérieux
    • Bio-Rad Laboratories, Inc.
    • AccuBioTech Co., Ltd.
    • Acon Laboratories, Inc.

 “*” marked represents similar segmentation in other categories in the respective section.              

Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By Disease Type
      • Market Snippet, By Technology
      • Market Snippet, By Test Location
      • Market Snippet, By End User
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • PEST Analysis
    • PORTER’s Analysis
    • Regulatory Scenario
  4. Global Infectious Disease Diagnostics Market, By Product Type, 2016 – 2026 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Kits & Reagents
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Instruments
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
  5. Global Infectious Disease Diagnostics Market, By Disease Type, 2016 – 2026 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2016 – 2026
      • Segment Trends
    • HIV
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Hepatitis
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Healthcare Associated Infections (HAIs)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Human Papillomavirus (HPV)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Tuberculosis (TB)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Influenza
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
  6. Global Infectious Disease Diagnostics Market, By Technology, 2016 – 2026 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2016 – 2026
      • Segment Trends
    • Immunodiagnostics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Polymerase Chain Reaction (PCR)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Next Generation Sequencing (NGS)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
  7. Global Infectious Disease Diagnostics Market, By Test Location, 2016 – 2026 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2016 – 2026
      • Segment Trends
    • Laboratory Testing
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Point of Care Testing
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
  8. Global Infectious Disease Diagnostics Market, By End User, 2016 – 2026 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2016 – 2026
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Pathology/Diagnostic Laboratories
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Research Institutes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Home-Care Settings
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
  9. Global Infectious Disease Diagnostics Market, By Region, 2016 – 2026 (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2026
    • North America
      • Market Size and Forecast, By Product Type, 2016 – 2026 (US$ Mn)
      • Market Size and Forecast, By Disease Type, 2016 – 2026 (US$ Mn)
      • Market Size and Forecast, By Technology, 2016 – 2026 (US$ Mn)
      • Market Size and Forecast, By Test Location, 2016 – 2026 (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2026 (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2026 (US$ Mn)
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast, By Product Type, 2016 – 2026 (US$ Mn)
      • Market Size and Forecast, By Disease Type, 2016 – 2026 (US$ Mn)
      • Market Size and Forecast, By Technology, 2016 – 2026 (US$ Mn)
      • Market Size and Forecast, By Test Location, 2016 – 2026 (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2026 (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2026 (US$ Mn)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Product Type, 2016 – 2026 (US$ Mn)
      • Market Size and Forecast, By Disease Type, 2016 – 2026 (US$ Mn)
      • Market Size and Forecast, By Technology, 2016 – 2026 (US$ Mn)
      • Market Size and Forecast, By Test Location, 2016 – 2026 (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2026 (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2026 (US$ Mn)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of APAC
    • Latin America
      • Market Size and Forecast, By Product Type, 2016 – 2026 (US$ Mn)
      • Market Size and Forecast, By Disease Type, 2016 – 2026 (US$ Mn)
      • Market Size and Forecast, By Technology, 2016 – 2026 (US$ Mn)
      • Market Size and Forecast, By Test Location, 2016 – 2026 (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2026 (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2026 (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Africa
      • Market Size and Forecast, By Product Type, 2016 – 2026 (US$ Mn)
      • Market Size and Forecast, By Disease Type, 2016 – 2026 (US$ Mn)
      • Market Size and Forecast, By Technology, 2016 – 2026 (US$ Mn)
      • Market Size and Forecast, By Test Location, 2016 – 2026 (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2026 (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2026 (US$ Mn)
        • Central Africa
        • South Africa
        • North Africa
    • Middle East
      • Market Size and Forecast, By Product Type, 2016 – 2026 (US$ Mn)
      • Market Size and Forecast, By Disease Type, 2016 – 2026 (US$ Mn)
      • Market Size and Forecast, By Technology, 2016 – 2026 (US$ Mn)
      • Market Size and Forecast, By Test Location, 2016 – 2026 (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2026 (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2026 (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
  10. Competitive Landscape
    • Company Profiles
      • Danaher Corporation
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Abbott Laboratories
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Becton, Dickinson, and Company
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • F.Hoffmann La-Roche Ltd.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Trinity Biotech Plc
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Cardinal Health, Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • BioMérieux
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Bio-Rad Laboratories, Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • AccuBioTech Co., Ltd.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Acon Laboratories, Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
  11. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 44 market data tables and 50 figures on "Infectious Disease Diagnostics Market - Global forecast to 2026”.

Research Methodology

Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:

  • Primary Research (Trade Surveys and Experts Interviews)
  • Desk Research
  • Proprietor Data Analytics Model

In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.


Smiley face

Coherent Market Insights desk research is based on a principle set of research techniques:

  • National level desk research: It Includes research analysis of regional players, regional regulatory bodies, regional trade associations, and regional organization.
  • Multinational level desk research: The research team keeps a track of multinational players, global regulatory bodies, global trade associations, and global organization.

Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:

  • Governmental bodies, National and international social welfare institutions, and organizations creating economic policies among others.
  • Trade association, National and international media and trade press.
  • Company Annual reports, SEC filings, Corporate Presentations, press release, news, and specification sheet of manufacturers, system integrators, brick and mortar - distributors and retailers, and third party online commerce players.
  • Scientific journals, and other technical magazines and whitepapers.

Smiley face

Preliminary Data Mining

The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.

Data Standardization:

Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.

Coherent Statistical model

We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:

  • Micro-economic indicators
  • Macro-economic indicators
  • Environmental indicators
  • Socio-political indicators
  • Technology indicators

Data Processing

Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.

Data Validation

This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:

  • It provides first-hand information on the market dynamics, outlook, and growth parameters.
  • Industry experts validates the estimates which helps the company to cement the on-going research study.
  • Primary research includes online surveys, face-to face interviews, and telephonic interviews.

The primary research is conducted with the ecosystem players including, but not limited to:

  • Raw Material Suppliers
  • Manufacturers
  • System Integrators
  • Distributors
  • End-users

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.